Researchers found that while sweat biomarkers remain stable, plasma biomarkers show significant inflammatory changes after a ...

Heart failure occurs when the heart cannot ... mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364, European Heart Journal (2024).

Doxazosin was recently withdrawn from this trial after ... failure (CHF). [30] There was no difference in the primary end point, fatal coronary heart disease, or nonfatal myocardial infarction ...

Heart disease remains the leading cause of death worldwide, and developing new therapeutic approaches constitutes an urgent healthcare priority. Almost one-third of patients surviving myocardial ...

The study, published in the European Heart Journal—Cardiovascular ... patients with preserved left ventricular function after a myocardial infarction. Of these, 324 patients could not be ...

While iterative developments have improved outcomes of patients with myocardial infarction, mortality in patients with acute ...

Breast cancer survivors who developed incident myocardial infarction or heart failure exhibited increased risk for adverse oncologic outcomes, according to a population-based cohort study.The findings ...

While conducting the study, the researchers tracked data from more than 10,000 patients who presented with type 2 diabetes, ...

Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...